Cornerstone Genomics
- Biotech or pharma, therapeutic R&D
- Diagnostics
- Other R&D services
Understanding how an individual’s genome influences their health is driving the need for innovative genome interpretation software solutions world-wide. Cornerstone Genomics has developed CodeXome® an advanced genome interpretation cloud platform that reclassifies genetic variants, predicts protein function, and identify potential therapeutic targets with blazing speed and exquisite precision. Our innovative use of gene evolution complemented with AI/ML features distinguishes CodeXome from competitors, and overcomes existing prolonged delays in finding targets for rare and complex inherited diseases as well as cancers.
Address
FrederickMaryland
United States
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}